NIH-funded clinical trial – marks first major advance in therapy in 40 years Lucentis effective for proliferative diabetic retinopathy. A clinical trial funded by the National Institutes of Health has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferative diabetic retinopathy. The trial, conducted by the Diabetic Retinopathy Clinical Research Network (DRCR.net) compared Lucentis with a type of laser therapy
Read more
Head Office Mailing Address
1427 Clarkview Road, STE 200, Baltimore, MD 21209